close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Centogene N.V. - Common Shares (NQ:CNTG)

0.3250 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Centogene N.V. - Common Shares

< Previous 1 2 3 Next >
News headline image
CENTOGENE to Participate in Upcoming Conferences in August
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Regains Compliance With Nasdaq Listing Requirements
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Biodatabank Reveals Unique Genetic Variants in World's Largest Niemann-Pick Type C1 Disease Cohort
Results Published in European Journal of Human Genetics Demonstrate Unprecedented Insights to Accelerate Potential Treatment Options 
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Announces Approval of All Resolutions Tabled at 2023 Annual General Meeting
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE and Lifera, a Biopharma Company Owned by the PIF, Enter Strategic Collaboration – Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing and Securing CENTOGENE $30 Million Investment
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Receives Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Reports Full Year 2022 Financial Results
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE to Participate in Upcoming Conferences in May
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Receives Nasdaq Non-Compliance Notice
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Accelerates Global Genetic Data Interpretation, Launching FilterTool Application as Accessory to CentoCloud® Bioinformatics Pipeline
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE to Participate in Upcoming Conferences in April
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Launches NEW CentoGenome®, World’s Most Comprehensive Whole Genome Sequencing Solution for Diagnosis of Rare and Neurodegenerative Diseases
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Appoints Ian Rentsch as Chief Commercial Officer and General Manager - Pharma
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE to Participate in Upcoming Conferences in March
From Centogene NV
Via GlobeNewswire
News headline image
In the Lead-Up to Rare Disease Day, CENTOGENE Expands Observational Study to Advance the Genetic Understanding of Frontotemporal Dementia (FTD)
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Regains Compliance With Nasdaq Listing Requirements
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE to Participate in Upcoming Conferences in February in the Lead Up to Rare Disease Day
From Centogene NV
Via GlobeNewswire
News headline image
Twist Bioscience and CENTOGENE Launch Three Panels to Advance Rare Disease and Hereditary Cancer Research and Support Diagnostics
From Twist Bioscience Corporation
Via Business Wire
News headline image
CENTOGENE and Denali Therapeutics Extend World’s Largest Observational Study on Parkinson’s Disease Genetics
Working together to deliver data-driven, informative genotyping answers to accelerate and de-risk drug discovery, development, and commercialization for Parkinson’s disease (PD) 
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Announces Its Attendance at the 41st Annual J.P. Morgan Healthcare Meeting and Fierce JPM Week in San Francisco
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Reports Second Quarter and First Half 2022 Financial Results
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Receives Nasdaq Non-Compliance Notice
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE to Participate in Upcoming Conferences in December
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Announces Changes to Supervisory Board, Including Appointment of Mary Sheahan
Adding significant financial expertise with an impressive track record in value creation 
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE to Participate in Upcoming Conferences in November
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Launches Rare and Neurodegenerative Disease Biodata Network
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE to Participate in Upcoming Partnering Conferences in October
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Reaches 12,500 Patient Milestone in World’s Largest Observational Study on Parkinson’s Disease Genetics
From Centogene NV
Via GlobeNewswire
News headline image
Dammam Valley and Arcensus GmbH to establish Saudi-German Genomic Center in Riyadh
Via ACN Newswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today